FDA Inspection 1195160 — Strides Pharma Science Limited

Strides Pharma Science Limited — FEI 3004554612

The FDA completed an inspection of Strides Pharma Science Limited on December 9, 2022 in Bangalore. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 9, 2022
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bangalore (India)